NSAIDs: Old acquaintance in the pipeline for cancer treatment and prevention─ Structural modulation, mechanisms of action, and bright future

S Ramos-Inza, AC Ruberte, C Sanmartin… - Journal of Medicinal …, 2021 - ACS Publications
The limitations of current chemotherapeutic drugs are still a major issue in cancer treatment.
Thus, targeted multimodal therapeutic approaches need to be strategically developed to …

Photoactive and luminescent transition metal complexes as anticancer agents: A guiding light in the search for new and improved cancer treatments

BS McGhie, JR Aldrich-Wright - Biomedicines, 2022 - mdpi.com
Cancer continues to be responsible for the deaths of more than 9 million people worldwide
each year. Current treatment options are diverse, but low success rates, particularly for those …

Rising interest in the development of metal complexes in cancer immunotherapy

ZY Li, QH Shen, ZW Mao, CP Tan - Chemistry–An Asian …, 2022 - Wiley Online Library
Metal complexes have shown great potential in cancer immunotherapy. This review briefly
introduces the basic concepts and strategies of cancer immunotherapy and summarizes the …

[HTML][HTML] Small-molecule compounds target paraptosis to improve cancer therapy

Y Wang, X Wen, N Zhang, L Wang, D Hao… - Biomedicine & …, 2019 - Elsevier
According to its different occurrence mechanism, programmed cell death (PCD) is divided
into apoptosis, autophagy, necrosis, paraptosis and so on. Paraptosis is morphologically …

Metal complexes or chelators with ROS regulation capacity: Promising candidates for cancer treatment

X Li, Y Wang, M Li, H Wang, X Dong - Molecules, 2021 - mdpi.com
Reactive oxygen species (ROS) are rapidly eliminated and reproduced in organisms, and
they always play important roles in various biological functions and abnormal pathological …

Antiproliferative activities of diimine-based mixed ligand copper (II) complexes

N Kordestani, HA Rudbari, AR Fernandes… - ACS combinatorial …, 2020 - ACS Publications
A series of Cu (diimine)(X-sal)(NO3) complexes, where the diimine is either 2, 2′-bipyridine
(bpy) or 1, 10-phenanthroline (phen) and X-sal is a monoanionic halogenated …

Lysosome-targeted cyclometalated iridium (III) complexes: JMJD inhibition, dual induction of apoptosis, and autophagy

JJ Lu, XR Ma, K Xie, MR Chen, B Huang, RT Li… - Metallomics, 2022 - academic.oup.com
A series of cyclometalated iridium (III) complexes with the formula [Ir (C^ N) 2 L](PF6)(C^ N=
2-phenylpyridine (ppy, in Ir-1), 2-(2-thienyl) pyridine (thpy, in Ir-2), 2-(2, 4-difluorophenyl) …

Dynamic Ir (III) Photosensors for the Major Human Drug-Metabolizing Enzyme Cytochrome P450 3A4

M Denison, JJ Ahrens, MN Dunbar… - Inorganic …, 2023 - ACS Publications
Probing the activity of cytochrome P450 3A4 (CYP3A4) is critical for monitoring the
metabolism of pharmaceuticals and identifying drug–drug interactions. A library of Ir (III) …

Targeting paraptosis in cancer: opportunities and challenges

F Chen, H Tang, X Cai, J Lin, L Xiang, R Kang… - Cancer Gene …, 2024 - nature.com
Cell death can be classified into two primary categories: accidental cell death and regulated
cell death (RCD). Within RCD, there are distinct apoptotic and non-apoptotic cell death …

Tuning the organelle specificity and cytotoxicity of iridium (III) photosensitisers for enhanced phototheranostic applications

JH Zhu, GX Xu, J Shum, LCC Lee… - Chemical …, 2021 - pubs.rsc.org
Luminescent cyclometallated iridium (III) complexes with a polyhedral oligomeric
silsesquioxane (POSS) unit were designed as efficient theranostic agents that displayed …